Kaustubh Kulkarni

MUMBAI/NEW DELHI (Reuters) - Slower government approval for testing new medicines is threatening India's aspirations to be a fast-growing, low-cost hub for clinical trials, and has prompted some drugs firms...

MUMBAI (Reuters) - Indian drugmaker Ranbaxy Laboratories Ltd has recalled its generic version of Pfizer Inc's cholesterol-lowering drug Lipitor in the United States after certain batches were found to contain...

MUMBAI (Reuters) - Indian drugmaker Ranbaxy Laboratories Ltd has recalled its generic version of Pfizer Inc's cholesterol-lowering drug Lipitor in the United States after certain batches were found to contain...

MUMBAI/LONDON (Reuters) - India's highest court will hear final arguments starting this week in a landmark case over drug patents that could change the rules for the country's healthcare sector...

MUMBAI/LONDON (Reuters) - India's highest court will hear final arguments starting this week in a landmark case over drug patents that could change the rules for the country's healthcare sector...

CHENNAI, India (Reuters) - For Ramaiyah Venkat, a retired Indian schoolteacher, the two-hour bus journey every three months to get free insulin is worth it even if he has to...

CHENNAI, India (Reuters) - For Ramaiyah Venkat, a retired Indian schoolteacher, the two-hour bus journey every three months to get free insulin is worth it even if he has to...